Ken Griffin Synlogic, Inc. Transaction History

Citadel Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.91 - $14.63 $13,648 - $219,420	14,998 New	14,998 $14,000
Q1 2022 May 16, 2022	SELL	$1.63 - $2.55 $18,407 - $28,797	-11,293 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.27 - $3.0 $1,670 - $2,208	-736 Reduced 6.12%	11,293 $27,000
Q3 2021 Nov 15, 2021	SELL	$2.45 - $4.1 $33,819 - $56,596	-13,804 Reduced 53.44%	12,029 $36,000
Q2 2021 Aug 16, 2021	BUY	$3.0 - $4.39 $24,459 - $35,791	8,153 Added 46.11%	25,833 $100,000
Q1 2021 May 17, 2021	BUY	$2.2 - $5.05 $38,896 - $89,284	17,680 New	17,680 $63,000
Q3 2020 Nov 16, 2020	SELL	$1.85 - $2.57 $121,456 - $168,725	-65,652 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.59 - $2.51 $104,386 - $164,786	65,652 New	65,652 $133,000
Q1 2020 May 15, 2020	SELL	$1.39 - $3.19 $18,737 - $43,001	-13,480 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.96 - $2.81 $26,420 - $37,878	13,480 New	13,480 $35,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.